MARATTO

article · Diabetic Medicine

Feasibility and benefits of continuous glucose monitoring for type 1 diabetes in Rwanda: A real‐world 12‐month continuation phase

Abstract

CGM-related improvements in HbA1c and TIR among Rwandans living with T1D were maintained for at least 24 months. CGM should be considered as an important tool to improve diabetes self-management in LMICs.

Research topics

  • Diabetes Management and Research
  • Diabetes and associated disorders
  • Diabetes Management and Education

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1111/dme.70284

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.